DD114607A5 - - Google Patents

Info

Publication number
DD114607A5
DD114607A5 DD177438A DD17743874A DD114607A5 DD 114607 A5 DD114607 A5 DD 114607A5 DD 177438 A DD177438 A DD 177438A DD 17743874 A DD17743874 A DD 17743874A DD 114607 A5 DD114607 A5 DD 114607A5
Authority
DD
German Democratic Republic
Application number
DD177438A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD114607A5 publication Critical patent/DD114607A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
DD177438A 1973-03-26 1974-03-25 DD114607A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732314985 DE2314985A1 (de) 1973-03-26 1973-03-26 1-(imidazol-1-yl)-isochinoline und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD114607A5 true DD114607A5 (xx) 1975-08-12

Family

ID=5875934

Family Applications (1)

Application Number Title Priority Date Filing Date
DD177438A DD114607A5 (xx) 1973-03-26 1974-03-25

Country Status (13)

Country Link
US (1) US3914236A (xx)
JP (1) JPS49126684A (xx)
AT (1) AT337183B (xx)
BE (1) BE812841A (xx)
DD (1) DD114607A5 (xx)
DE (1) DE2314985A1 (xx)
ES (1) ES424436A1 (xx)
FR (1) FR2223024B1 (xx)
GB (1) GB1464289A (xx)
HU (1) HU168524B (xx)
IL (1) IL44478A (xx)
NL (1) NL7403829A (xx)
ZA (1) ZA741917B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54151990A (en) * 1978-04-17 1979-11-29 Beiersdorf Ag Novel condensated nitrogenncontained heterocyclic compound and its manufacture
US5716972A (en) * 1993-01-13 1998-02-10 Smithkline Beecham Corporation Pyridyl substituted imidazoles
DE4215587A1 (de) * 1992-05-12 1993-11-18 Bayer Ag Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone
US5446071A (en) * 1994-11-18 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
EP1020445B1 (en) 1997-10-02 2008-08-13 Eisai R&D Management Co., Ltd. Fused pyridine derivatives
KR101158270B1 (ko) * 2003-04-16 2012-06-20 훈츠만 어드밴스트 머티리얼스(스위처랜드) 게엠베하 1-이미다졸릴메틸-치환된-2-나프톨 및 저온 경화용촉진제로서 이들의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH485412A (de) * 1967-04-26 1970-02-15 Agripat Sa Mittel zur Bekämpfung tierischer und pflanzlicher Schädlinge
GB1170188A (en) * 1967-09-15 1969-11-12 Bayer Ag N-trityl-imidazoles and salts and uses thereof
DE1964996C3 (de) * 1969-12-24 1978-11-30 Bayer Ag, 5090 Leverkusen 9-Azolyl-fluoren-9-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel zur Regulierung des Pflanzenwachstums
FR2076625A5 (xx) * 1970-01-21 1971-10-15 Rhone Poulenc Sa

Also Published As

Publication number Publication date
IL44478A0 (en) 1974-06-30
ES424436A1 (es) 1977-05-16
IL44478A (en) 1977-07-31
GB1464289A (en) 1977-02-09
ATA245274A (de) 1976-10-15
AT337183B (de) 1977-06-10
ZA741917B (en) 1975-03-26
BE812841A (fr) 1974-09-26
FR2223024B1 (xx) 1978-01-06
NL7403829A (xx) 1974-09-30
DE2314985A1 (de) 1974-10-17
FR2223024A1 (xx) 1974-10-25
AU6709874A (en) 1975-09-25
JPS49126684A (xx) 1974-12-04
HU168524B (xx) 1976-05-28
US3914236A (en) 1975-10-21

Similar Documents

Publication Publication Date Title
AU476761B2 (xx)
AU465372B2 (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU471343B2 (xx)
AU476714B2 (xx)
FR2223024B1 (xx)
AU472848B2 (xx)
AU476696B2 (xx)
AU466283B2 (xx)
AU477823B2 (xx)
AR200885A1 (xx)
AU477824B2 (xx)
AU471461B2 (xx)
AU476873B1 (xx)
AU479562A (xx)
CH559450A5 (xx)
CH562363A (xx)
CH566700A5 (xx)
AU479539A (xx)
CH1530573A4 (xx)
BG25982A3 (xx)